# ED Initiated Oral Naltrexone for AUD

> **NCT04817410** · PHASE1 · COMPLETED · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 30 (actual)

## Conditions studied

- Alcohol Use Disorder

## Interventions

- **DRUG:** Emergency Department Initiated Oral Naltrexone

## Key facts

- **NCT ID:** NCT04817410
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-28
- **Primary completion:** 2023-10-31
- **Final completion:** 2023-11-02
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2025-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04817410

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04817410, "ED Initiated Oral Naltrexone for AUD". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04817410. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*